Tag: Andrea L. Richardson

Harvard researchers at the Dana-Farber Cancer Institute have discovered a “gene activity signature” that predicts a high risk of cancer recurrence in some breast tumors that have been treated with commonly used chemotherapy drugs. Despite their resistance to drugs of the anthracycline class, the breast cancers bearing this gene signature probably still will be vulnerable…